Technical Analysis for BICTF - Biocure Technology Inc

Grade Last Price % Change Price Change
grade D 0.1824 1.11% 0.0020
BICTF closed up 1.11 percent on Wednesday, October 23, 2019, on 1.43 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical BICTF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 1.11%
Gapped Up Strength 1.11%
New 52 Week Closing Low Bearish 1.33%
Hot IPO Pullback Bullish Swing Setup 1.33%
Narrow Range Bar Range Contraction 1.33%
New 52 Week Low Weakness 1.33%
Down 3 Days in a Row Weakness 1.33%
Down 4 Days in a Row Weakness 1.33%

Older signals for BICTF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Biocure Technology Inc. develops and commercializes biosimilar pharmaceutical products in South Korea. The company is developing Interferon Beta 1b for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It is also developing a foot and mouth disease vaccine, a hair growth production product, and a breast cancer detection kit. Biocure Technology Inc. is headquartered in Vancouver, Canada.
Medicine Medical Specialties RTT Cancer Clinical Medicine Chemotherapy Breast Cancer Monoclonal Antibodies Multiple Sclerosis Genentech Amgen Macular Edema Macular Degeneration Cancer Detection Growth Factors Bone Marrow Transplant Neutropenia Treatment Of Multiple Sclerosis
Is BICTF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.32
52 Week Low 0.18
Average Volume 2,103
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.2197
Average True Range 0.0193
ADX 0.0
+DI 29.0227
-DI 67.2984
Chandelier Exit (Long, 3 ATRs ) 0.2621
Chandelier Exit (Short, 3 ATRs ) 0.2379
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line -0.0232
MACD Signal Line -0.0112
MACD Histogram -0.012
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1824
Resistance 3 (R3) 0.1824 0.1824 0.1824
Resistance 2 (R2) 0.1824 0.1824 0.1824 0.1824
Resistance 1 (R1) 0.1824 0.1824 0.1824 0.1824 0.1824
Pivot Point 0.1824 0.1824 0.1824 0.1824 0.1824
Support 1 (S1) 0.1824 0.1824 0.1824 0.1824 0.1824
Support 2 (S2) 0.1824 0.1824 0.1824 0.1824
Support 3 (S3) 0.1824 0.1824 0.1824
Support 4 (S4) 0.1824